Prot #CD07_TNBC: A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)

Project: Research project

Project Details

StatusActive
Effective start/end date7/8/197/8/22

Funding

  • Amarex Clinical Research (Prot #CD07_TNBC)
  • CytoDyn Inc. (Prot #CD07_TNBC)